Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 62022TN0585

Case T-585/22: Action brought on 20 September 2022 — Trus v EUIPO — Unilab (ARTRESAN)

OJ C 418, 31.10.2022, p. 54–54 (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

31.10.2022   

EN

Official Journal of the European Union

C 418/54

Action brought on 20 September 2022 — Trus v EUIPO — Unilab (ARTRESAN)

(Case T-585/22)

(2022/C 418/69)

Language in which the application was lodged: English

Parties

Applicant: Mariusz Trus (Lublin, Poland) (represented by: W. Włodarczyk, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Unilab LP (Rockville, Maryland, United States)

Details of the proceedings before EUIPO

Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal

Trade mark at issue: European Union word mark ARTRESAN — European Union trade mark No 4 304 937

Procedure before EUIPO: Cancellation proceedings

Contested decision: Decision of the First Board of Appeal of EUIPO of 20 July 2022 in joined Cases R 1428/2020-1 and R 1481/2020-1

Form of order sought

The applicant claims that the Court should:

—

annul the contested decision to the extent that the trade mark at issue was maintained for the goods in Class 5 ‘therapeutic creams for joints; food supplements for medical purposes’;

—

declare the mark revoked also for the above mentioned goods in Class 5;

—

order EUIPO and the intervener to pay the costs incurred in the present proceedings and in the proceedings before the Board of Appeal.

Pleas in law

—

Infringement of Article 58(1)(a) of Regulation (EU) 2017/1001 of the European Parliament and of the Council;

—

Infringement of the first sentence of Article 94(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.
Top